Fenofibrate Tablet
Product Images NDC 60760-318

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 60760-318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fenofibrate Structural Formula (36e14bc9 F02e 4e72 8c0c 53c5b138e39c 01)

Chemical structure diagram of fenofibrate. The diagram shows the molecular structure with labeled carbon (C), hydrogen (H), chlorine (Cl), and oxygen (O) atoms arranged in a complex organic molecule.*

FDA Label Image

Feno (Fenofibrate 60760 318 30)

Packaging label for Fenofibrate Tablets, USP 160 mg, with a quantity of 30 tablets. The product is manufactured by Mankind Pharma Ltd., New Delhi, India, and packaged by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. The label includes storage instructions to keep the product at controlled room temperature (15°-30°C or 59°-86°F) and states 'Rx only.' Various lot, expiration, and RX numbers are represented by placeholders or question marks.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.